phrykt

ELI LILLY & Co (LLY): who owns it and who trades it

As of Nov 13, 2026, LLY insiders reported 121 open-market sales worth $1.1B and no purchases in the last 12 months, with 2% of the sale value made under pre-set 10b5-1 plans. The largest seller was Lilly Endowment Inc (10% owner), with $1.1B. 13 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 13, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Eli Lilly

From the latest filings

Overall: about as much buying as selling. Insiders and Congress mostly sold. Funds mostly bought. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns LLY

4,592 funds and institutions reported LLY shares worth $941B at the end of Q2 2026, about 83% of the company. The largest holder is Lilly Endowment Inc with 9.6%.

Funds and institutions (13F) 83%Everyone else 17%

10 largest owners, by share of the company

Lilly Endowment Inc9.6%
BlackRock, Inc.7.2%
Vanguard Capital Management LLC5.7%
PNC Financial Services Group, Inc.5.4%
State Street Corp3.8%
FMR LLC (Fidelity)3.0%
Capital Research Global Investors2.2%
Vanguard Portfolio Management LLC2.2%
Geode Capital Management, LLC2.2%
Morgan Stanley1.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Lilly Endowment Inc90.38M9.60%$108B-2%
BlackRock, Inc.67.54M7.17%$81B+2%
Vanguard Capital Management LLC53.53M5.68%$64.2B+0%
PNC Financial Services Group, Inc.51.32M5.45%$61.6BNo change
State Street Corp36.22M3.85%$43.4B+2%
FMR LLC (Fidelity)28.46M3.02%$34.1B+8%
Capital Research Global Investors20.87M2.22%$25B-15%
Vanguard Portfolio Management LLC20.86M2.21%$25B-1%
Geode Capital Management, LLC20.31M2.16%$24.3B+1%
Morgan Stanley16.23M1.72%$19.5B+5%
Capital World Investors15.90M1.69%$19.1B+2%
T. Rowe Price Associates13.91M1.48%$16.7B-1%
JPMorgan Chase & Co12.60M1.34%$15.5B–
Norges Bank11.47M1.22%$13.8B–
Bank of America Corp11.27M1.20%$13.5B+1%
Wellington Management Group LLP11.00M1.17%$13.2B-18%
State Farm Mutual Automobile Insurance Co10.76M1.14%$12.9BNo change
Primecap Management Co9.17M0.97%$11B-1%
Northern Trust Corp8.80M0.93%$10.6B-0%
Goldman Sachs Group Inc7.65M0.81%$9.2B+21%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, LLY insiders reported $0 of open-market purchases and $1.1B of sales. 2% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$1.1B
121 trades, 5 people
Sales under a 10b5-1 plan
2%
Share of sale value
Latest trade
Nov 2, 2026
Filed Nov 3, 2026

Purchases and sales by month

$324M$324MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 2, 2026Anat HakimVice presidentSale plan5,000$1,402.52$7MForm 4
Aug 17, 2026Patrik JonssonVice presidentSale plan6,500$1,175.10$7.6MForm 4
Aug 10, 2026Donald A ZakrowskiVice presidentSale plan2,000$1,185.01$2.4MForm 4
Aug 7, 2026Anat HakimVice presidentSale plan5,000$1,190.00$6MForm 4
Jun 10, 2026Ilya YuffaVice presidentSale plan2,500$1,150.77$2.9MForm 4
May 6, 2026Lilly Endowment IncOtherSale2,208$996.18$2.2MForm 4
May 6, 2026Lilly Endowment IncOtherSale13,620$995.23$13.6MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale930$1,088.97$1MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale3,575$1,090.18$3.9MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale1,224$1,091.05$1.3MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale1,072$1,092.56$1.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale1,322$1,093.58$1.4MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale420$1,094.70$460KForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale475$1,095.74$520KForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale6,408$1,097.41$7MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale9,573$1,098.55$10.5MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale20,447$1,099.36$22.5MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale14,937$1,100.46$16.4MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale20,668$1,101.42$22.8MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale34,434$1,102.41$38MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale40,956$1,103.31$45.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale21,042$1,104.40$23.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale24,362$1,105.46$26.9MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale13,701$1,106.42$15.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale16,650$1,107.37$18.4MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale13,247$1,108.42$14.7MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale8,513$1,109.32$9.4MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale3,464$1,110.37$3.8MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale2,085$1,111.21$2.3MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale4,652$1,112.43$5.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale9,053$1,113.77$10.1MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale4,342$1,114.37$4.8MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale2,210$1,115.76$2.5MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale2,737$1,116.69$3.1MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale1,070$1,087.80$1.2MForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale895$1,085.11$971KForm 4
Jan 7, 2026Lilly Endowment Inc10% ownerSale7,684$1,086.75$8.4MForm 4
Jan 5, 2026Lilly Endowment Inc10% ownerSale1,390$1,085.01$1.5MForm 4
Dec 29, 2025Lilly Endowment Inc10% ownerSale3,593$1,085.04$3.9MForm 4
Dec 24, 2025Lilly Endowment Inc10% ownerSale2,629$1,085.17$2.9MForm 4
Dec 23, 2025Lilly Endowment Inc10% ownerSale240$1,085.04$260KForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale9,249$1,109.45$10.3MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,043$1,108.71$5.6MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale1,340$1,110.53$1.5MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale1,260$1,079.37$1.4MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale651$1,080.73$704KForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale1,606$1,081.90$1.7MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale160$1,082.93$173KForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale3,069$1,084.70$3.3MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,604$1,086.07$6.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale6,508$1,086.94$7.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,589$1,087.97$6.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,284$1,088.91$5.8MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale1,907$1,089.85$2.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale7,794$1,107.48$8.6MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale18,254$1,092.06$19.9MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale9,050$1,093.16$9.9MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale6,246$1,094.03$6.8MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale2,083$1,094.79$2.3MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale1,061$1,096.33$1.2MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale4,198$1,097.44$4.6MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale4,639$1,098.32$5.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale6,545$1,099.49$7.2MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale8,527$1,100.34$9.4MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale11,854$1,101.45$13.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale7,456$1,102.35$8.2MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale6,274$1,103.58$6.9MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,196$1,104.41$5.7MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale2,494$1,105.32$2.8MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale3,662$1,106.57$4.1MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale800$1,077.99$862KForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale882$1,076.00$949KForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale2,481$1,073.74$2.7MForm 4
Nov 25, 2025Lilly Endowment Inc10% ownerSale5,927$1,091.12$6.5MForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale744$1,072.78$798KForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale2,954$1,073.60$3.2MForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale14,105$1,069.48$15.1MForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale120,016$1,068.18$128MForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale1,710$1,071.37$1.8MForm 4
Nov 24, 2025Lilly Endowment Inc10% ownerSale2,778$1,070.35$3MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale9,871$1,050.27$10.4MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale5,506$1,051.48$5.8MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale160$1,066.15$171KForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale2,885$1,052.36$3MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale1,987$1,053.46$2.1MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale1,629$1,054.42$1.7MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale2,495$1,055.45$2.6MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale1,546$1,056.40$1.6MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale5,064$1,057.58$5.4MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale9,729$1,058.46$10.3MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale23,916$1,059.66$25.3MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale7,582$1,060.53$8MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale10,492$1,061.56$11.1MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale9,051$1,062.52$9.6MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale8,576$1,063.57$9.1MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale3,378$1,064.43$3.6MForm 4
Nov 21, 2025Lilly Endowment Inc10% ownerSale1,459$1,065.57$1.6MForm 4
Nov 20, 2025Lilly Endowment Inc10% ownerSale6,701$1,051.37$7MForm 4
Nov 20, 2025Lilly Endowment Inc10% ownerSale3,188$1,054.51$3.4MForm 4
Nov 20, 2025Lilly Endowment Inc10% ownerSale16,845$1,050.36$17.7MForm 4

Latest 100 of 121 trades in the last 12 months.

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Lilly Endowment Inc10% owner–$1.1BMay 6, 2026
Anat HakimEVP, GC & Secretary–$13MNov 2, 2026
Patrik JonssonEVP & President, LLY Int'l–$7.6MAug 17, 2026
Ilya YuffaEVP&Pres, LLY USA&Global Capab–$2.9MJun 10, 2026
Donald A ZakrowskiSVP, Finance, & CAO–$2.4MAug 10, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

LLY short interest

Low short interest. 0.8% of LLY shares are sold short: about 1 share in 130. Over the last 12 reports the number of shares short went down 14%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.21M LLY shares were sold short, 0.8% of the shares outstanding, up 3.6% from the report before. At the average daily volume of 2.71M shares, buying them all back would take about 2.7 trading days (days to cover).

Shares short, % of all shares

0.77%May 15Oct 301.15%

Days to cover

2.7May 15Oct 304.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.21M0.77%+4%2.71M2.7
Oct 15, 20266.96M0.74%-1%2.29M3.0
Sep 30, 20267.04M0.75%-6%2.40M2.9
Sep 15, 20267.52M0.80%-5%2.20M3.4
Aug 31, 20267.89M0.84%+20%2.64M3.0
Aug 14, 20266.56M0.70%-28%3.11M2.1
Jul 31, 20269.12M0.97%-11%2.32M3.9
Jul 15, 202610.28M1.09%+10%2.53M4.1
Jun 30, 20269.35M0.99%-3%3.62M2.6
Jun 15, 20269.66M1.03%-1%3.21M3.0
May 29, 20269.80M1.04%+16%3.31M3.0
May 15, 20268.43M0.90%+7%3.33M2.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded LLY

Since Nov 16, 2024, 21 members of Congress reported 24 purchases and 41 sales of LLY. The latest was a sale by David J. Taylor on Nov 3, 2026, reported Nov 12, 2026.

Purchases 24Sales 41

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Nov 3, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfNov 12, 2026Report
Oct 20, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfNov 10, 2026Report
Jul 10, 2026Dan Newhouse (R-WA)Partial sale$1K–$15KSpouseJul 17, 2026Report
Jul 1, 2026Michael A. Rulli (R-OH)Sale$1K–$15KSelfAug 7, 2026Report
Jun 10, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$50K–$100KSelfJul 2, 2026Report
Apr 14, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMay 8, 2026Report
Apr 8, 2026Lizzie Fletcher (D-TX)Partial sale$1K–$15KSelfMay 1, 2026Report
Apr 2, 2026Byron Donalds (R-FL)Purchase$1K–$15KSpouseMay 13, 2026Report
Apr 2, 2026Byron Donalds (R-FL)Purchase$1K–$15KSelfMay 13, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Sale$1K–$15KSelfJul 21, 2026Report
Mar 13, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfApr 7, 2026Report
Feb 26, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfMar 6, 2026Report
Feb 13, 2026Angus S. King, Jr. (I-ME)Sale$1K–$15KSpouseMar 24, 2026Report
Feb 9, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfFeb 20, 2026Report
Jan 16, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfFeb 2, 2026Report
Jan 2, 2026Michael A. Rulli (R-OH)Purchase$1K–$15KSelfAug 7, 2026Report
Dec 29, 2025Angus S. King, Jr. (I-ME)Purchase$1K–$15KSpouseJan 26, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Dec 10, 2025David J. Taylor (R-OH)Sale$1K–$15KSelfDec 19, 2025Report
Dec 2, 2025Michael A. Rulli (R-OH)Sale$1K–$15KSelfAug 7, 2026Report
Nov 21, 2025John Boozman (R-AR)Partial sale$1K–$15KJointDec 8, 2025Report
Nov 18, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfDec 15, 2025Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Oct 24, 2025Shelley Moore Capito (R-WV)Purchase$1K–$15KSpouseNov 4, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 22, 2025John Boozman (R-AR)Purchase$1K–$15KJointSep 12, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
Aug 14, 2025David J. Taylor (R-OH)Purchase$15K–$50KSelfSep 2, 2025Report
Aug 14, 2025David J. Taylor (R-OH)Purchase$1K–$15KSelfSep 2, 2025Report
Aug 11, 2025John Boozman (R-AR)Purchase$1K–$15KJointSep 12, 2025Report
Jul 16, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseAug 13, 2025Report
Jul 10, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 9, 2025Lisa C. McClain (R-MI)Partial sale$1K–$15KSpouseAug 13, 2025Report
Jun 3, 2025Jonathan L. Jackson (D-IL)Sale$15K–$50KJointJul 14, 2025Report
May 30, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJun 6, 2025Report
May 21, 2025Jonathan L. Jackson (D-IL)Sale$1K–$15KSpouseAug 25, 2025Report
May 14, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 19, 2025Report
May 13, 2025Josh Gottheimer (D-NJ)Partial sale$1K–$15KJointJun 11, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$100K–$250KSelfJun 22, 2025Report
May 6, 2025Val T. Hoyle (D-OR)Partial sale$1K–$15KSpouseSep 12, 2025Report
May 5, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 6, 2025Report
May 1, 2025Josh Gottheimer (D-NJ)Purchase$1K–$15KJointJun 11, 2025Report
Apr 23, 2025Jonathan L. Jackson (D-IL)Purchase$1K–$15KSpouseAug 25, 2025Report
Apr 21, 2025Jonathan L. Jackson (D-IL)Purchase$15K–$50KJointMay 13, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Apr 15, 2025Tommy Tuberville (R-AL)Sale$15K–$50KJointMay 15, 2025Report
Apr 11, 2025Dan Newhouse (R-WA)Partial sale$1K–$15KSpouseMay 16, 2025Report
Apr 9, 2025Josh Gottheimer (D-NJ)Partial sale$1K–$15KJointMay 14, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfApr 28, 2025Report
Apr 7, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Eli Lilly company events

Eli Lilly filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Aug 5, 2026ResultsReleased financial results. Filing
  3. May 20, 2026AnnouncementEli Lilly and Company completed its offering of $750 million of its Floating Rate Notes due 2028, $500 million of its Floating Rate Notes due 2029 (the “2029 Floating Rate Notes” and, together with the 2028 Floating Rate Notes, the “Floating Rate Notes”), $750 million of its 4.150% Notes due 2029… Filing
  4. May 7, 2026VoteReported shareholder vote results. Filing
  5. Apr 30, 2026ResultsReleased financial results. Filing
  6. Feb 4, 2026ResultsReleased financial results. Filing
  7. Nov 21, 2025LeadershipReported a change among its top officers or directors, or their pay. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Eli Lilly makes money

United States brought in 67% of Eli Lilly's revenue ($43.5B of $65.2B) in 2025. Europe was next, at 18%.

By region, 2025

United States$43.5B · 67%
Europe$11.6B · 18%
Rest Of World$6.1B · 9%
Japan$2.1B · 3%
China$2B · 3%

From Eli Lilly's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 12, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Eli Lilly financials

Famous investors that hold LLY

13 of the 50 well-known investors we track reported holding LLY in their latest 13F filing. The largest position is Ken Fisher's, worth $6.3B.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 20265.42M$6.3B1.8%+7%
Ken Griffin · Citadel AdvisorsQ2 2026945,456$1.1B0.7%+291%
Jeremy Grantham · GMOQ3 2026753,925$872M1.9%+1%
Israel Englander · Millennium ManagementQ2 2026182,678$219M0.2%-34%
Cathie Wood · ARK Investment ManagementQ3 2026107,838$125M0.7%+40%
Ray Dalio · Bridgewater AssociatesQ2 202687,023$104M0.4%+23%
Larry Robbins · Glenview Capital ManagementQ2 202657,771$69.3M1.4%New
Paul Tudor Jones · Tudor Investment CorpQ2 202630,885$37M0.2%-75%
George Soros · Soros Fund ManagementQ3 202622,199$25.7M0.5%No change
Stanley Druckenmiller · Duquesne Family OfficeQ2 202612,380$14.8M0.3%New
Steve Cohen · Point72 Asset ManagementQ2 202610,476$12.6M0.0%-89%
Bill Nygren · Harris Associates (Oakmark)Q2 2026431$517K0.0%-4%
Jim Simons · Renaissance TechnologiesQ3 2026433$504K0.0%-98%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named LLY in the last 120 days.

FiledHolderFormStake
Oct 19, 2026LILLY ENDOWMENT, INC.13G/A9.6%
Oct 19, 2026LILLY ENDOWMENT, INC.13G/A9.6%

Questions about ELI LILLY & Co (LLY) stock

Eli Lilly is a drugmaker based in Indianapolis. Its best-known product today is tirzepatide, sold as Mounjaro for type 2 diabetes since May 2022 and as Zepbound for weight management since November 2023.

What is Lilly Endowment?

Lilly Endowment is a private charitable foundation in Indianapolis. J.K. Lilly Sr. and his sons Eli and J.K. Jr. founded it in 1937 with gifts of 17,500 shares of Eli Lilly stock. It has long been the company's largest single shareholder. A filing in July 2026 put its holding at about 9.6% of the company. In November 2025 the rise in Lilly stock pushed its assets past $100 billion, a first for a US private foundation.

The endowment and the company share a name and a history, but they have no legal connection today.

Why is Lilly Endowment listed as an insider?

A holder of more than 10% of a company's stock counts as an insider. It must report its trades on Form 4, just like executives do. That is why the endowment appears in the insider table next to Lilly's officers, labelled "10% owner".

Earlier reports put its stake above that line, for example about 11% in 2024. It has since dipped just under 10%, so the label reflects its history in the filings.

Why does Lilly Endowment sell so much Lilly stock?

The endowment does not explain individual sales in its filings. It has reported sales in many years, for example in 2021 and through 2025 and 2026. A single day often shows several small sales at slightly different prices. Each line is one batch of trades at a weighted average price, not a separate decision.

Because the endowment is a foundation that holds mainly one stock, its sales can be large in dollars even when they are small next to its total stake. Read insider buying vs insider selling for why one seller can dominate the totals.

Who are the other Lilly insiders?

Dave Ricks has been chief executive since January 2017 and chair of the board since June 2017. Many executive sales on this page are marked as made under pre-set Rule 10b5-1 plans, where the dates and amounts are fixed months ahead.

Why is index fund ownership so high?

After the endowment, the largest holders are index and asset managers such as BlackRock, Vanguard and State Street. They hold Lilly mostly because it is one of the largest companies in the S&P 500 and other indexes their funds track. See what institutional ownership means.

Who owns the most LLY stock?

The largest reported owner of ELI LILLY & Co (LLY) is Lilly Endowment Inc, with 9.6% of the company. In total, 4,592 funds and institutions reported holding LLY at the end of Q2 2026, together about 83% of the shares. See the largest owners.

Are LLY insiders buying or selling?

In the last 12 months, LLY insiders reported no open-market purchases and 121 sales worth $1.1B. The latest trade was on Nov 2, 2026. See every trade.

What is the short interest in LLY?

As of Oct 30, 2026, 7.21M LLY shares were sold short, 0.8% of the shares outstanding, up 3.6% from the report before. At the average daily volume of 2.71M shares, buying them all back would take about 2.7 trading days (days to cover). See the history.

Have members of Congress traded LLY?

Yes. 21 members of Congress reported 24 purchases and 41 sales of LLY since Nov 16, 2024. The latest was reported on Nov 12, 2026. See the trades.

How does Eli Lilly make money?

United States brought in 67% of Eli Lilly's revenue ($43.5B of $65.2B) in 2025. Europe was next, at 18%. See the full split.

Which famous investors hold LLY?

13 of the 50 well-known investors we track reported LLY in their latest 13F filing, including Ken Fisher, Ken Griffin, Jeremy Grantham. The largest position is worth $6.3B. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.